Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease

Abstract Background There have been a number of reports implicating the association of microRNAs (miRs) and the MAPK signaling pathway with the dopaminergic neuron, which is involved in the development of Parkinson’s disease (PD). The present study was conducted with aims of exploring the role of mi...

Full description

Bibliographic Details
Main Authors: Yue Dong, Li-Li Han, Zhong-Xin Xu
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Molecular Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s10020-018-0059-9
id doaj-634b0343dd4f497580963193f1f52f2e
record_format Article
spelling doaj-634b0343dd4f497580963193f1f52f2e2020-11-25T02:05:51ZengBMCMolecular Medicine1076-15511528-36582018-11-0124111310.1186/s10020-018-0059-9Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s diseaseYue Dong0Li-Li Han1Zhong-Xin Xu2Department of Neurology , China-Japan Union Hospital, Jilin UniversityDepartment of Neurology, Cangzhou Central HospitalDepartment of Neurology , China-Japan Union Hospital, Jilin UniversityAbstract Background There have been a number of reports implicating the association of microRNAs (miRs) and the MAPK signaling pathway with the dopaminergic neuron, which is involved in the development of Parkinson’s disease (PD). The present study was conducted with aims of exploring the role of miR-96 in the activation of iNOS and apoptosis of dopaminergic neuron through the MAPK signaling pathway in mice with PD. Methods The miR and the differentially expressed gene in PD were screened out and the relationship between them was verified. A mouse model of PD induced by MPTP and was then constructed and treated with miR-96 mimic/inhibitor and CACNG5 overexpression plasmid to extract nigral dopaminergic neuron for the purpose of detecting the effect of miR-96 on PD. The TH and iNOS positive neuronal cells, the apoptotic neuronal cells by TUNEL staining, and expression of miR-96, CACNG5, iNOS, p38MAPK, p-p38MAPK, c-Fos, Bax, and Bcl-2 in substantia nigra dopaminergic neuronal tissues were evaluated. Results The results obtained from the aforementioned procedure were then verified by cell culture of the SH-SY5Y cells, followed by treatment with miR-96 mimic/inhibitor, CACNG5 overexpression plasmid and the inhibitor of the MAPK signaling pathway. CACNG5 was confirmed as a target gene of miR-96. The inhibition of miR-96 resulted in a substantial increase in nigral cells, TH positive cells and expression of CACNG5 and Bcl-2 in nigral dopaminergic neuronal tissues, and a decrease in iNOS positive cells, apoptotic neuronal cells, and expression of iNOS, p38MAPK, p-p38MAPK, c-Fos, and Bax. Conclusion The above results implicated that the downregulation of miR-96 inhibits the activation of iNOS and apoptosis of dopaminergic neuron through the blockade of the MAPK signaling pathway by promoting CACNG5 in mice with PD.http://link.springer.com/article/10.1186/s10020-018-0059-9MicroRNA-96CACNG5Parkinson’s diseaseMAPK signaling pathwayInducible nitric oxide synthaseDopaminergic neuron
collection DOAJ
language English
format Article
sources DOAJ
author Yue Dong
Li-Li Han
Zhong-Xin Xu
spellingShingle Yue Dong
Li-Li Han
Zhong-Xin Xu
Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
Molecular Medicine
MicroRNA-96
CACNG5
Parkinson’s disease
MAPK signaling pathway
Inducible nitric oxide synthase
Dopaminergic neuron
author_facet Yue Dong
Li-Li Han
Zhong-Xin Xu
author_sort Yue Dong
title Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
title_short Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
title_full Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
title_fullStr Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
title_full_unstemmed Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson’s disease
title_sort suppressed microrna-96 inhibits inos expression and dopaminergic neuron apoptosis through inactivating the mapk signaling pathway by targeting cacng5 in mice with parkinson’s disease
publisher BMC
series Molecular Medicine
issn 1076-1551
1528-3658
publishDate 2018-11-01
description Abstract Background There have been a number of reports implicating the association of microRNAs (miRs) and the MAPK signaling pathway with the dopaminergic neuron, which is involved in the development of Parkinson’s disease (PD). The present study was conducted with aims of exploring the role of miR-96 in the activation of iNOS and apoptosis of dopaminergic neuron through the MAPK signaling pathway in mice with PD. Methods The miR and the differentially expressed gene in PD were screened out and the relationship between them was verified. A mouse model of PD induced by MPTP and was then constructed and treated with miR-96 mimic/inhibitor and CACNG5 overexpression plasmid to extract nigral dopaminergic neuron for the purpose of detecting the effect of miR-96 on PD. The TH and iNOS positive neuronal cells, the apoptotic neuronal cells by TUNEL staining, and expression of miR-96, CACNG5, iNOS, p38MAPK, p-p38MAPK, c-Fos, Bax, and Bcl-2 in substantia nigra dopaminergic neuronal tissues were evaluated. Results The results obtained from the aforementioned procedure were then verified by cell culture of the SH-SY5Y cells, followed by treatment with miR-96 mimic/inhibitor, CACNG5 overexpression plasmid and the inhibitor of the MAPK signaling pathway. CACNG5 was confirmed as a target gene of miR-96. The inhibition of miR-96 resulted in a substantial increase in nigral cells, TH positive cells and expression of CACNG5 and Bcl-2 in nigral dopaminergic neuronal tissues, and a decrease in iNOS positive cells, apoptotic neuronal cells, and expression of iNOS, p38MAPK, p-p38MAPK, c-Fos, and Bax. Conclusion The above results implicated that the downregulation of miR-96 inhibits the activation of iNOS and apoptosis of dopaminergic neuron through the blockade of the MAPK signaling pathway by promoting CACNG5 in mice with PD.
topic MicroRNA-96
CACNG5
Parkinson’s disease
MAPK signaling pathway
Inducible nitric oxide synthase
Dopaminergic neuron
url http://link.springer.com/article/10.1186/s10020-018-0059-9
work_keys_str_mv AT yuedong suppressedmicrorna96inhibitsinosexpressionanddopaminergicneuronapoptosisthroughinactivatingthemapksignalingpathwaybytargetingcacng5inmicewithparkinsonsdisease
AT lilihan suppressedmicrorna96inhibitsinosexpressionanddopaminergicneuronapoptosisthroughinactivatingthemapksignalingpathwaybytargetingcacng5inmicewithparkinsonsdisease
AT zhongxinxu suppressedmicrorna96inhibitsinosexpressionanddopaminergicneuronapoptosisthroughinactivatingthemapksignalingpathwaybytargetingcacng5inmicewithparkinsonsdisease
_version_ 1724936568566710272